Rapid Dose Therapeutics Corp (TSE:DOSE) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Rapid Dose Therapeutics Corp. has announced an extension for its private placement financing, aiming to raise up to $6 million through the sale of common shares, with the first tranche already closed at $309,000. This fundraising effort will help the Canadian biotech firm, known for its innovative QuickStrip™ drug delivery technology, in advancing its business goals.
For further insights into TSE:DOSE stock, check out TipRanks’ Stock Analysis page.